BTI British American Tobacco p.l.c. IFRS Annual reports only
Cigarettes · NYSE · SEC CIK 1303523 · Reporting currency GBP
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: GBP | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 25.61B | 25.87B | 27.28B | 27.66B | 25.68B |
| R&D expense | 358.00M | 380.00M | 408.00M | 323.00M | 304.00M |
| Operating income | 10.00B | 2.74B | -15.75B | 10.52B | 10.23B |
| Interest expense | 1.66B | 1.70B | 1.79B | 1.60B | 1.44B |
| Pretax income | 9.86B | 3.54B | -17.06B | 9.32B | 9.16B |
| Income tax | 2.09B | 357.00M | -2.87B | 2.48B | 2.19B |
| Net income | 7.76B | 3.07B | -14.37B | 6.67B | 6.80B |
| EPS (basic) | 3.51 | 1.37 | -6.47 | 2.93 | 2.97 |
| EPS (diluted) | 3.49 | 1.36 | -6.47 | 2.92 | 2.96 |
| Dividends declared per share | 2.45 | 2.40 | 2.36 | 2.31 | 2.18 |
| Weighted avg. shares (diluted) | 2.20B | 2.23B | 2.23B | 2.27B | 2.30B |
| Balance sheet | |||||
| Cash & equivalents | 3.83B | 5.30B | 4.66B | 3.45B | 2.81B |
| Receivables | 3.80B | 3.60B | 3.62B | 4.37B | 3.95B |
| Inventory | 4.38B | 4.62B | 4.94B | 5.67B | 5.28B |
| Current assets | 12.68B | 14.29B | 14.19B | 15.41B | 12.81B |
| PP&E, netmay include right-of-use assets (IFRS) | 4.48B | 4.38B | 4.58B | 4.87B | 4.95B |
| Goodwill | 38.92B | 41.13B | 41.09B | 47.96B | 43.19B |
| Total assets | 109.29B | 118.90B | 118.72B | 153.55B | 137.37B |
| Current liabilities | 14.52B | 18.74B | 15.67B | 17.85B | 15.14B |
| Short-term debt | 3.36B | 4.31B | 4.32B | 4.41B | 3.99B |
| Long-term debt | 31.71B | 32.64B | 35.41B | 38.73B | 35.67B |
| Total debt | 35.07B | 36.95B | 39.73B | 43.14B | 39.66B |
| Total liabilities | 61.15B | 68.90B | 65.78B | 77.84B | 69.96B |
| Shareholders' equity | 46.03B | 47.96B | 50.88B | 73.68B | 65.42B |
| Net debt | 31.24B | 31.65B | 35.07B | 39.69B | 36.85B |
| Cash flow statement | |||||
| Operating cash flow | 6.34B | 10.12B | 10.71B | 10.39B | 9.72B |
| Capital expenditure | 551.00M | 486.00M | 460.00M | 523.00M | 527.00M |
| Free cash flow | 5.79B | 9.64B | 10.25B | 9.87B | 9.19B |
| Investing cash flow | 1.39B | 1.38B | -296.00M | -705.00M | -1.14B |
| Financing cash flow | -8.76B | -10.63B | -9.31B | -8.88B | -8.75B |
| Stock-based compensation | 90.00M | 74.00M | 74.00M | 85.00M | 78.00M |
| Dividends paid | 5.24B | 5.21B | 5.05B | 4.92B | 4.90B |
| Share buybacks | 1.11B | 698.00M | 0 | 2.01B | 0 |
Free plan shows the latest 5 periods; Pro shows all 13 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· This company does not report gross profit in XBRL.
· Amounts are in the company's reporting currency, GBP, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.